PharmD Info

A forum for Indian Pharmacy Professionals

Important: Registered today to have the complete access on this forum --- Register Here
Its an inter-professional and collaborative learning platform for the doctors and other healthcare professionals to discuss on various healthcare issues and views with pharmacy professionals. Pharmacist also can assist and share your ideas for the better therapeutic outcomes based on clear evidence. E.g: Drug Information, Decision Analysis and EBM.
Forum rules: The contents of the pharmdinfo.com, such as text, graphics, images, and other material contained on the pharmdinfo.com Site ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Pharmdinfo.com Site!

If you think you may have a medical emergency, call your doctor or 108 immediately. pharmdinfo.com does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site
  • User avatar
  • User avatar
  • User avatar
#246
US-based Abbott on Wednesday launched in India a professional version of its flash glucose monitoring system, an easy to use latest glucose monitoring wearable device for people with diabetes. The professional version (meant only for doctors) is being launched for the first time in the world in India, which has the second-largest diabetes population after China.

The product, launched for patients in seven countries in Europe since September, has already been used by over 15,000 patients, said Matthew Bates, director - R&D*, Abbott Diabetes Care.
The system consists of a round sensor, slightly larger than a 10-rupee coin. A doctor can fit this water-resistant and disposable sensor on the back of the upper arm of a person with diabetes. The sensor will remain on the back of the arm for up to 14 days, continuously measuring glucose in interstitial fluid (just under the skin) through a small filament that is inserted just under the skin. It records glucose levels every 15 minutes, capturing up to 1340 glucose readings over 14 days.
When the person returns to the doctor after two weeks, the doctor uses a Flash Glucose Monitoring reader to scan the sensor and download the glucose results that are stored in the sensor to assess the data (Ambulatory Glucose Profile or AGP graph) using a software.
INTERESTING READ: Abbott goes glocal
The patient will have to pay Rs 1,999 for the sensor. The reader with the doctor costs Rs 5,000 and can be used multiple times, said Dilip Rajan, Country Head of Abbott's diabetes care unit in India. Currently, the Indian market for glucose monitoring devices is estimated in the range of $100 million. Globally, the market is about $12 billion, led by Roche, Johnson & Johnson and Abbott.
India's population living with diabetes today is 65.1 million and this is expected to cross 100 million in another 15 years. Poor diabetes control cause increased risk of health complications including nerve problems, heart diseases, retinopathy and foot ulcers.
"Numerous patients in India have poor sugar control, despite the medicines and physician advice," says Dr Shashank Joshi, a leading endocrinologist and diabetologist and president, Association of Physicians of India.
Current diabetes monitoring tools are limiting since they do not reveal a complete picture of the glucose fluctuations that a person goes through during a day. A complete glucose profile over 14 days including nights will help doctors make more informed treatment decisions, which in turn will help patients manage their diabetes better, says Dr Joshi.
He says though a few versions of wearable glucose monitoring systems are available in the market, high humidity in Indian conditions cause to give wrong data - an example being glucose monitoring watches launched in India in 2003.
*The statement was wrongly attributed to Robert Ford, senior vice-president, Diabetes Care, Abbott. The change has been made.
Similar Topics
Topics Statistics Last post
0 Replies 
16 Views
by Admin
29 Oct 2017, 12:06
0 Replies 
702 Views
by Admin
05 Oct 2017, 07:02
0 Replies 
885 Views
by Admin
21 Jun 2017, 13:50
0 Replies 
1596 Views
by Prajith
20 Dec 2016, 09:16
0 Replies 
888 Views
by Dr Abhilash Thomas
11 Oct 2017, 14:45

Tags

The case is to be notified to the DIO of the distr[…]

PharmD Info Online Group Discussion Disc[…]

The Pharmacy Council of India (PCI) has launched a[…]

Indian Association of Colleges of Pharmacy. A/C N[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES